Instalab
logoInstalab

3-Hydroxyisovaleric Acid

Urine Test
Investigate possible biotin shortfalls that blood vitamin levels can miss.
4.9 (3,295 reviews)
Tested by Genova Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a 3-Hydroxyisovaleric Acid test?

This test is most useful if any of these apply to you.

Investigating Possible Low Biotin
May add supporting evidence when your diet or nutrition history raises concern, with other causes of elevation checked.
Pregnant or Planning to Be
Pregnancy studies support a link with biotin status, but routine testing hasn't been shown to improve pregnancy outcomes.
Taking Valproate
Helps interpret a urine result affected by treatment; it doesn't measure your medication's safety or effectiveness.
Investigating Hair or Skin Changes
Can contribute when biotin deficiency is suspected, though hair loss and rashes have many causes this result cannot distinguish.
Investigating a Possible Metabolic Disorder
Useful within a urine organic acid profile when symptoms, family history, or other tests suggest an inherited disorder.

About 3-Hydroxyisovaleric Acid

Urinary 3-hydroxyisovaleric acid can rise when your body has too little biotin to process leucine efficiently. Small controlled feeding studies showed this biochemical change while blood biotin measurements remained relatively unchanged. That makes it useful supporting evidence when a biotin shortfall is suspected, but several other causes can produce the same result.

Its established clinical role is within urine organic acid profiles used to investigate inherited metabolic disorders. Its use for detecting marginal biotin deficiency rests mainly on small human studies. Routine screening, personal optimization targets, and repeated testing to improve long-term health haven't been established.

Where It Comes From

Leucine is an amino acid used to build proteins. Your body also breaks it down through a series of chemical reactions. One step requires both biotin and an enzyme called 3-methylcrotonyl-CoA carboxylase, or MCC. When that step slows, more of the material entering the pathway can be converted into 3-HIA and leave through your urine.

A related compound, 3-hydroxyisovaleryl carnitine, forms when the same chemical group is attached to carnitine. It is a separate molecule with its own measurements and evidence. This urine result concerns the free acid.

What the Biotin Studies Show

In controlled studies, adults ate diets designed to reduce biotin availability. Urinary 3-HIA increased over several weeks, while serum biotin was a less sensitive indicator of the early change. These experiments establish that inadequate biotin can raise urinary 3-HIA. They don't establish that biotin deficiency is the most common explanation for an elevated result in everyday practice.

The marker also performed better than two other organic acids examined in these experiments. Urinary 3-hydroxypropionic acid identified only 5 of 21 volunteers with experimentally induced marginal deficiency. Methylcitric acid was inconsistent between studies. Among these organic acids, 3-HIA was the most sensitive indicator.

Much of this evidence comes from timed urine collections under controlled conditions. A single sample collected during ordinary life has more uncertainty around recent food intake, supplements, and urine concentration. There is no universally accepted preventive target, and a personal baseline doesn't resolve those limitations.

Pregnancy studies also support a relationship between increased urinary 3-HIA and reduced biotin availability. They measured biochemical responses, however, and didn't establish that screening with this marker improves pregnancy outcomes. An elevated result isn't evidence that a baby has been harmed.

Inherited Disorders of Leucine Breakdown

Several inherited disorders can raise urinary 3-HIA. The accompanying acids help distinguish them because each disorder interrupts a different part of metabolism.

  • Isovaleric acidemia: an earlier step in leucine breakdown is impaired. Isovalerylglycine is a characteristic urine finding, and 3-HIA can also increase.
  • MCC deficiency: reduced activity of the biotin-dependent enzyme can cause substantial increases in 3-HIA and 3-methylcrotonylglycine.
  • Biotinidase deficiency and holocarboxylase synthetase deficiency: problems recycling biotin or attaching it to enzymes affect several reactions at once, producing a broader organic acid pattern.
  • Later steps in leucine breakdown: 3-methylglutaconic aciduria type I and HMG-CoA lyase deficiency produce characteristic combinations of 3-methylglutaconic acid, 3-hydroxy-3-methylglutaric acid, and other acids that can include 3-HIA.

Severe forms can present in infancy, but milder or later presentations occur. Newborn screening uses different markers for different disorders. C5-OH is relevant to MCC deficiency and several related conditions, C5 is used in screening for isovaleric acidemia, and biotinidase screening measures enzyme activity. None is the same measurement as free 3-HIA in urine.

The Number Doesn't Predict Severity by Itself

Many people identified with MCC deficiency through newborn screening remain well despite pronounced biochemical abnormalities. Published screening experience suggests that more than nine in ten identified individuals appear to remain asymptomatic, although follow-up duration and ascertainment vary. A high urinary value therefore cannot predict an individual's clinical course.

The diagnosis, symptoms, companion metabolites, and response to illness matter. A substantial elevation can occur without symptoms, while an inherited disorder can sometimes produce a less striking profile between episodes.

What Research on a Related Molecule Adds

A study of 694 kidney transplant recipients measured 3-hydroxyisovaleryl carnitine in 24-hour urine, a related but different measurement. Higher excretion was associated with lower mortality during follow-up. Protein intake and muscle-related measures explained much of the variation, and accounting for those factors weakened the mortality association.

That finding doesn't establish a survival relationship for free urinary 3-HIA or show that raising either marker improves health. It does show why findings about the carnitine-bound molecule shouldn't be used as direct evidence about this test.

Changes During Serious Illness

Ketoacidosis can increase urinary 3-HIA. This is a dangerous disturbance in which ketones accumulate and make the blood too acidic. Studies found that urinary 3-HIA increased alongside the ketone 3-hydroxybutyrate, so an elevated result in that setting doesn't establish nutritional biotin deficiency.

An exploratory study also found increased urinary 3-HIA in children being treated for tuberculous meningitis. It used an NMR research method and compared a small group of affected children with controls. Its results haven't established this routine urine measurement as a test for meningitis or a general measure of illness severity.

When Results Can Be Misleading

  • HMB supplements: beta-hydroxy-beta-methylbutyrate is the same molecule as 3-HIA. Taking it can increase urinary excretion directly, without indicating a biotin shortfall.
  • A recent leucine load: a human challenge study found increased urinary 3-HIA during the five hours after a leucine dose, including in biotin-sufficient participants. This was a controlled supplement challenge; it doesn't establish the effect of every ordinary protein meal.
  • Valproate: treated individuals can excrete more 3-HIA. Laboratory experiments found that a valproate breakdown product inhibited MCC, and some treated individuals had reduced biotinidase activity. These findings support a drug effect but don't prove dietary biotin deficiency or show that the urine value measures medication safety.
  • Acute metabolic illness: ketoacidosis and some inherited metabolic crises can change the result substantially. Findings from those settings shouldn't be interpreted as a routine nutritional assessment.
  • Urine concentration and creatinine: results are commonly expressed relative to urine creatinine. This reduces the effect of dilution, but differences in creatinine excretion related to muscle mass or kidney function can still affect the ratio.
  • Collection and analysis: storage problems and overlapping chemical signals can complicate organic acid analysis. Results from different collection formats or analytical methods shouldn't be treated as interchangeable.

What Moves This Biomarker

Evidence-backed interventions that affect your 3-Hydroxyisovaleric Acid level

↓ Decrease
Biotin supplementation when inadequate biotin is limiting leucine breakdown
Biotin can lower urinary 3-HIA when reduced biotin availability is slowing the pathway. In a randomized trial of 26 pregnant women with increased urinary excretion, 300 micrograms daily for two weeks reduced 3-HIA compared with placebo. The trial measured a biochemical response and didn't establish improved pregnancy outcomes.
SupplementStrong Evidence
↑ Increase
A low-biotin diet containing substantial amounts of undenatured egg white
Sustained intake of undenatured egg white can reduce biotin absorption and raise urinary 3-HIA. In small controlled feeding studies, diets designed to deplete biotin produced progressive increases over several weeks. This reflects impaired biotin-dependent metabolism.
DietStrong Evidence
↓ Decrease
Prescribed oral biotin for confirmed biotinidase deficiency
Biotin treatment restores biotin availability in this inherited recycling disorder and can markedly reduce elevated urinary 3-HIA. Early treatment prevents many neurological and skin complications, although established hearing, vision, or neurological damage may not fully reverse.
MedicationStrong Evidence
↓ Decrease
Individualized protein restriction with carnitine and glycine treatment for isovaleric acidemia
In people with isovaleric acidemia, limiting excess leucine intake and providing alternative routes to remove accumulated compounds can reduce urinary 3-HIA. Observational reports describe lower or normalized excretion during treatment and recovery. The separate contribution of each treatment component hasn't been established in controlled trials.
DietModerate Evidence

Frequently Asked Questions

References

21 studies
  1. Donald M. Mock, Cindy L. Henrich, Nadine S. Carnell, Nell I. MockAmerican Journal of Clinical Nutrition2002
  2. Donald M. Mock, Cindy L. Henrich, Nadine S. Carnell, Phyllis Stumbo, Nell I. MockJournal of Nutrition2004
  3. Donald M. Mock, Shawna L. Stratton, Thomas D. Horvath, Anna Bogusiewicz, Nell I. Matthews, Cindy L. Henrich, Amanda M. Dawson, Horace Jack Spencer, Suzanne N. Owen, Gunnar Boysen, Jeffery H. MoranJournal of Nutrition2011
  4. Donald M. Mock, J. Gerald Quirk, Nell I. MockAmerican Journal of Clinical Nutrition2002

3-Hydroxyisovaleric Acid Testing Options

$405

See the chemical trail your metabolism leaves behind, and explore where your energy, gut, and nutrient pathways may be under strain.

Includes 49 biomarkers:
3-Hydroxyisovaleric Acid3-Indoleacetic AcidPhenylacetic AcidDHPPA3-Hydroxyphenylacetic Acid
$509

A comprehensive at-home nutritional and metabolic assessment that analyzes key biomarkers to reveal functional nutrient needs and imbalances.

90 biomarkers
FSA/HSA eligible
No Rx needed
HIPAA compliant